1. Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study. Issue 11 (27th November 2018) Authors: Tibaldi, Carmelo; Camerini, Andrea; Tiseo, Marcello; Mazzoni, Francesca; Barbieri, Fausto; Vittimberga, Isabella; Brighenti, Matteo; Boni, Luca; Baldini, Editta; Gilli, Annalisa; Honeywell, Richard; Chartoire, Myriam; Peters, Godefridus; Giovannetti, Elisa Journal: British journal of cancer Issue: Volume 119:Issue 11(2018) Page Start: 1326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗